Recent news on Quetiapine Fumarate

New Study Analyses Confirm Once-Daily SEROQUEL XR(TM) Extended ...  -  May 22, 2007
PR Newswire (press release),...(3) About a poster presentation entitled: Efficacy of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia This first

FDA Approves AstraZeneca’s Once-Daily SEROQUEL XR(TM) Extended ...  -  May 18, 2007
PipelineReview.com (press release),AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets,

FDA Approves AstraZeneca’s Once-Daily SEROQUEL XR  -  May 20, 2007
ag-IP-news Agency,LONDON - AstraZeneca announced in a press release that the US Food and Drug Administration (FDA) has approved SEROQUEL XR (quetiapine fumarate)

FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended ...  -  May 18, 2007
PR Newswire (press release),...has approved SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, a once-daily medicine for the treatment of schizophrenia in adult patients.

FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended ...  -  May 17, 2007
Earthtimes.orgWILMINGTON, Del., May 18 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved SEROQUEL XR(TM) (quetiapine fumarate)

FDA Approves Astrazeneca's Once-Daily Seroquel XR Extended-Release ...  -  May 18, 2007
Compliance Home,...(May 17, 2007)-- AstraZeneca announced that the FDA has approved SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets, a once-daily medicine for the

AstraZeneca's Plan, Icahn's Success, S&P Record: David Wilson  -  Apr 23, 2007
Bloomberg...to sell a generic version of the schizophrenia drug and has filed suit to overturn AstraZeneca's patent on its active ingredient, quetiapine fumarate.

SEROQUEL(R) Sustained Release Schizophrenia Data Presented at ECP ...  -  Mar 28, 2007
Drug Newswire (press release),The data demonstrated that the SEROQUEL(R) sustained release formulation (quetiapine fumarate sustained release), administered once daily,

AstraZeneca Sues Novartis to Block Generic Seroquel (Update1)  -  Apr 10, 2007
BloombergAstraZeneca claims the copies would infringe a patent it owns on quetiapine fumarate, the active ingredient in Seroquel. Sandoz's application challenges the

SEROQUEL(R) Sustained Release Schizophrenia Data presented at ECP ...  -  Mar 19, 2007
PipelineReview.com (press release),Announced clinical trial data for SEROQUEL® sustained release formulation (quetiapine fumarate sustained release), at the European Congress of Psychiatry

SEROQUEL(R) Sustained Release Schizophrenia Data Presented at ECP ...  -  Mar 19, 2007
Antara (press release),The data demonstrated that the SEROQUEL(R) sustained release formulation (quetiapine fumarate sustained release), administered once daily,

Seroquel Sustained Release Schizophrenia Data Presented at ECP ...  -  Mar 19, 2007
PharmaLive.com (press release),LONDON, March 18, 2007-AstraZeneca today announced clinical trial data for Seroquel sustained release formulation (quetiapine fumarate sustained release),

SEROQUEL(R) Sustained Release Schizophrenia Data Presented at ECP ...  -  Mar 18, 2007
Earthtimes.orgThe data demonstrated thatthe SEROQUEL(R) sustained release formulation (quetiapine fumarate sustainedrelease), administered once daily,

Clinical Trials Update: Feb. 20, 2007  -  Feb 20, 2007
Atlanta Journal Constitution (subscription),This study will evaluate the safety and efficacy of sustained-release quetiapine fumarate (Seroquel) for eight weeks to treat acute bipolar depression.

MediaSyndicate --- Free Press Release, PR, IR, News Post & Media ...  -  Feb 11, 2007
MediaSyndicate (press release)The exhaustive review examined 84 published studies on atypical antipsychotics such as Seroquel (quetiapine fumarate). Researchers found that not only is

The New Year in Psychiatry  -  18 Jan 2007
Psychiatric Times,The second generation antipsychotics were Zyprexa (olanzapine), Geodon (ziprasidone), Seroquel (quetiapine fumarate), and Risperdal (risperidone).

Lack of Awareness and Cultural Stigmas May Prevent Many Latinos ...  -  Dec 20, 2006
Hispanic PR Wire (press release),But there is good news for people with bipolar disorder: the US Food and Drug Administration (FDA) recently approved SEROQUEL(R) (quetiapine fumarate) for

Updated Bipolar Disorder Guidelines include Seroquel as a first ...  -  Nov 30, 2006
DG NewsThe guidelines consider Seroquelâ„¢ (quetiapine fumarate) as a first-line single medication for bipolar depression and a second-line option for the management

Lack of Awareness and Cultural Stigmas May Prevent Many Latinos ...  -  Dec 20, 2006
Hispanic PR Wire (press release),But there is good news for people with bipolar disorder: the US Food and Drug Administration (FDA) recently approved SEROQUEL(R) (quetiapine fumarate) for

Switching Drugs No Panacea in Schizophrenia  -  Dec 1, 2006
Psychiatric Times,...four so-called second generation medications, Zyprexa (olanzapine), Geodon (ziprasidone), Seroquel (quetiapine fumarate), and Risperdal (risperidone).

Older Schizophrenia Drug Called More Cost-Effective Than Newer Ones  -  Dec 1, 2006
Psychiatric Times,These were Zyprexa (olanzapine), Geodon (ziprasidone), Seroquel (quetiapine fumarate), and Risperdal (risperidone). The main result of the study,

AstraZeneca Announces New Program that Offers Significant and ...  09 Nov 2006
...immediately receive savings on AstraZeneca products, including NEXIUM® (esomeprazole), CRESTOR® (rosuvastatin), SEROQUEL® (quetiapine fumarate), TOPROL XL ... -Yahoo! News (press release) FDA Approves AstraZeneca's Seroquel® For Bipolar Depression ...  Oct 23, 2006
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved SEROQUEL® (quetiapine fumarate) for the treatment of patients with ... -Medical News Today (press release), FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression ...  Oct 24, 2006
FirstCall/ -- AstraZeneca (NYSE:AZN) today announced that the US Food and Drug Administration (FDA) has approved SEROQUEL(R) (quetiapine fumarate) for the ... -Drug Newswire (press release), After Alzheimer's disappointment, AstraZeneca seeks new uses for ...  Oct 13, 2006
Created in 1988 by tweaking an existing antipsychotic compound enough to merit a patent, 1 Seroquel (quetiapine fumarate) had the three things big pharma loves ... -Best Syndication, ASTRAZENECA SUBMITS EU AND CANADIAN REGULATORY FILINGS FOR ...  Oct 19, 2006
SEROQUEL® (quetiapine fumarate) has a well-established safety andefficacy profile and to date it is estimated that over 19 million peoplehave been treated ... -Webfinanser, FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression ...  Oct 20, 2006
AstraZeneca (NYSE: AZN - News) today announced that the US Food and Drug Administration (FDA) has approved SEROQUEL® (quetiapine fumarate) for the treatment ... -Yahoo! News (press release) AstraZeneca Submits EUd Canadian Regulatory Filings for Sustained ...  Oct 19, 2006
SEROQUEL® (quetiapine fumarate) has a well-established safety and efficacy profile and to date it is estimated that over 19 million people have been treated ... -PharmaLive.com (press release), AstraZeneca: FDA OKs Seroquel Bipolar Treatment  Oct 23, 2006
LONDON -(Dow Jones)- AstraZeneca Monday announced that the US Food and Drug Administration (FDA) has approved SEROQUEL (quetiapine fumarate) for the treatment ... -Therapeutics Daily (subscription) (press release), Seroquel SR submitted in Canada and Europe  Oct 20, 2006
AstraZeneca has made severel regulatory submissions for the sustained-release formulation of its antipsychotic Seroquel (quetiapine fumarate). ... -Therapeutics Daily (subscription) (press release), Schizophrenia :: AstraZeneca's SEROQUEL SR for Schizophrenia in EU ...  Oct 19, 2006
SEROQUEL® (quetiapine fumarate) has a well-established safety and efficacy profile and to date it is estimated that over 19 million people have been treated ... -SpiritIndia, COMUNICADO: New Data Offers Hope to Patients With Bipolar Disorder ...  Sep 18, 2006
Quetiapine (quetiapine fumarate) has a well-established safety and efficacy profile and to date over 16 million people have been treated with quetiapine ... -Europa Press

Drug Questions  Aug 30, 2006
...paid $26,493,119 in 2005 for olanzapine, $11,688,886 for risperidone (which is sold as Risperdal), and $13,279,737 for quetiapine fumarate (sold under the name ... -Monday Magazine

Updated Bipolar Disorder Guidelines include Seroquel as a first ...  -  Nov 30, 2006
DG NewsThe guidelines consider Seroquelâ„¢ (quetiapine fumarate) as a first-line single medication for bipolar depression and a second-line option for the management ...

Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar ...  -  Nov 17, 2006
DG NewsNovember 17, 2006 -- Results from the newly published BOLDER II (BipOLar DEpRession) study confirm that Seroquel® (quetiapine fumarate) has the potential as a ...

Switching Drugs No Panacea in Schizophrenia  -  Dec 1, 2006
MedPage Today,...perphenazine) with four so-called second generation medications, Zyprexa (olanzapine), Geodon (ziprasidone), Seroquel (quetiapine fumarate), and Risperdal ...

Old People Dying From Falls More Often  -  Nov 17, 2006
Health Sentinel...generation of antipsychotic drugs, or “atypicals� have been introduced including clozapine, risperidone, olanzapine, quetiapine, fumarate, ziprasidone, and ...

Quetiapine as effective as Risperidone for treatment of ...  Aug 23, 2006
The study QUARTZ ( Quetiapine Fumarate and Risperidone in the Treatment of Patients with Schizophrenia ) found that Quetiapine ( Seroquel ) presents similar ... -Xagena.it

Study Confirms Seroquel(R) as Effective as Risperidone for ...  Aug 3, 2006
ALDERLEY PARK, UK -- August 3, 2006 -- Seroquel® (quetiapine fumarate) demonstrated similar levels of efficacy to risperidone among schizophrenia patients ... -DG News

AstraZeneca submits NDA for Seroquel for schizophrenia  Aug 10, 2006
...a New Drug Application (NDA) with the US Food and Drug Administration (FDA) for a sustained release formulation of Seroquel (quetiapine fumarate) - Seroquel SR ... -Therapeutics Daily (subscription)

AstraZeneca Submits An NDA For Sustained Release Formulation ...  22 Jul 2006
SEROQUEL® (quetiapine fumarate) has a well-established safety and efficacy profile and to date over 16 million people have been treated worldwide. ... -Medical News Today

AstraZeneca Submits NDA For Sustained Release Formulation Of ...  Jul 19, 2006
New Drug Application (NDA) with the US Food and Drug Administration (FDA) for a sustained release formulation of SEROQUEL(R) (quetiapine fumarate) - SEROQUEL(R ... -Medical News Today

AstraZeneca Submits NDA for Sustained Release Formulation of ...  Jul 18, 2006
Drug Application (NDA) with the US Food and Drug Administration (FDA) for a sustained release formulation of SEROQUEL® (quetiapine fumarate) - SEROQUEL® SR ... -Yahoo! News

AstraZeneca Submits NDA For Sustained Release Formulation Of ...  Jul 18, 2006
...submitted a New Drug Application with the US Food and Drug Administration for a sustained release formulation of SEROQUEL (quetiapine fumarate) - SEROQUEL® SR ... -Trading Markets



Seroquel big, and could get bigger  Apr 23, 2006
...year. Seroquel, whose chemical name is quetiapine fumarate, belongs to a class of drugs known as atypical antipsychotics. Seroquel ... - The News Journal





AstraZeneca: Toprol Ruling Worsens Generic Woes  Jan 21, 2006
...two of AstraZeneca's other blockbuster products, anti-ulcerant Nexium (esomaprazole) and schizophrenia treatment Seroquel (quetiapine fumarate), have also been ... - Black Enterprise

for Bipolar Depression Treatment  Jan 18, 2006
...it has submitted a supplemental New Drug Application (sNDA) with the FDA to seek approval for a new indication for SEROQUEL® (quetiapine fumarate) for the ... - Pharmaceutical Processing

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional